Harsha Thirumurthy of the Perelman School of Medicine argued that we should waive COVID-19 vaccine patents for low-income countries. “We simply can’t bring an end to the pandemic—here in the U.S. or elsewhere—without rapidly closing the global vaccine gap,” he wrote. “And we can’t close that gap without waivers of patent protections that are keeping lower-income countries from manufacturing vaccines themselves.”